Skip to main content
OpenTrials

Clinical trial condition

Hormone Receptor Positive [HR+] and Human Epidermal Growth Factor Receptor 2 Negative [HER2-] Breast Carcinoma

Explore clinical trials studying Hormone Receptor Positive [HR+] and Human Epidermal Growth Factor Receptor 2 Negative [HER2-] Breast Carcinoma. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Hormone Receptor Positive [HR+] and Human Epidermal Growth Factor Receptor 2 Negative [HER2-] Breast Carcinoma trial results

Recruiting

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

NCT05985655

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +34 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • START Midwest Grand Rapids, Michigan, United States
  • START San Antonio San Antonio, Texas, United States
  • START Mountain Region West Valley City, Utah, United States
View all 13 locations
View Trial Details

Related conditions